董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Vasant Padmanabhan | -- | Director | 57 | 21.62万美元 | 未持股 | 2025-09-12 |
| Thomas Erickson | 男 | Director | 74 | 22.88万美元 | 未持股 | 2025-09-12 |
| John J. Tracy | 男 | Director | 71 | 24.00万美元 | 未持股 | 2025-09-12 |
| Malissia R. Clinton | 女 | Director | 56 | 24.00万美元 | 未持股 | 2025-09-12 |
| Claudia N. Drayton | 女 | Director | 57 | 21.81万美元 | 未持股 | 2025-09-12 |
| Jim D. Kever | 男 | Director | 72 | 22.00万美元 | 未持股 | 2025-09-12 |
| Kevin S. Moore | 男 | Director | 70 | 24.50万美元 | 未持股 | 2025-09-12 |
| Charles G. McClure, Jr. | 男 | Chairman of the Board | 72 | 40.00万美元 | 未持股 | 2025-09-12 |
| Jeffrey A. Graves | 男 | Director,President and Chief Executive Officer | 64 | 653.56万美元 | 未持股 | 2025-09-12 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Reji Puthenveetil | 男 | Executive Vice President, Additive Solutions and Chief Commercial Officer | 56 | 231.21万美元 | 未持股 | 2025-09-12 |
| Phyllis Nordstrom | 女 | Executive Vice President, interim Chief Financial Officer,Chief People Officer and Chief Administrative Officer, Principal Financial Officer and Principal Accounting Officer | 47 | 209.67万美元 | 未持股 | 2025-09-12 |
| Joseph Zuiker | 男 | Executive Vice President, Engineering and Operations | 61 | 未披露 | 未持股 | 2025-09-12 |
| Andrew W. B. Wright | 男 | Senior Vice President, General Counsel and Secretary | 56 | 未披露 | 未持股 | 2025-09-12 |
| Charles W. Hull | 男 | Executive Vice President and Chief Technology Officer for Regenerative Medicine | 85 | 288.50万美元 | 未持股 | 2025-09-12 |
| Jeffrey A. Graves | 男 | Director,President and Chief Executive Officer | 64 | 653.56万美元 | 未持股 | 2025-09-12 |
董事简历
中英对照 | 中文 | 英文- Vasant Padmanabhan
-
Vasant Padmanabhan于2014年6月加入公司担任技术运营高级副总裁。加入Thoratec之前，Padmanabhan从2012年5月到2014年5月担任Implantable Defibrillator Business at Medtronic, Inc.（一家医疗设备制造商）产品开发副总裁。在此之前，Padmanabhan从2007年7月到2012年5月担任CRDM Patient Management Development with Medtronic产品开发副总裁。Padmanabhan从1996年1月到2007年7月在Medtronic及其美国和欧洲子公司担任多个研发职位。Padmanabhan持有印度特里奇National Institute of Technology电子和通讯工程学士学位；Rutgers University生物医疗工程博士学位。
Vasant Padmanabhan,has served as President, Global Ear, Nose & Throat Business Unit, President Global Research & Development and as a member of the Executive Committee for Smith+Nephew, a global medical devices business operating in the markets for advanced surgical devices, since August 2016. Prior to joining Smith+Nephew, Dr. Padmanabhan served as Senior Vice President for Thoratec Corporation from June 2014 until its acquisition by St. Jude Medical, Inc. in October 2015. Prior to joining Thoratec, Dr. Padmanabhan served in several roles of increasing responsibility for 18 years with Medtronic plc in their Cardiac Rhythm Management business, including as Vice President of Product Development for the Implantable Defibrillator Business and as Vice President of Connected Care R&D and Operations. - Vasant Padmanabhan于2014年6月加入公司担任技术运营高级副总裁。加入Thoratec之前，Padmanabhan从2012年5月到2014年5月担任Implantable Defibrillator Business at Medtronic, Inc.（一家医疗设备制造商）产品开发副总裁。在此之前，Padmanabhan从2007年7月到2012年5月担任CRDM Patient Management Development with Medtronic产品开发副总裁。Padmanabhan从1996年1月到2007年7月在Medtronic及其美国和欧洲子公司担任多个研发职位。Padmanabhan持有印度特里奇National Institute of Technology电子和通讯工程学士学位；Rutgers University生物医疗工程博士学位。
- Vasant Padmanabhan,has served as President, Global Ear, Nose & Throat Business Unit, President Global Research & Development and as a member of the Executive Committee for Smith+Nephew, a global medical devices business operating in the markets for advanced surgical devices, since August 2016. Prior to joining Smith+Nephew, Dr. Padmanabhan served as Senior Vice President for Thoratec Corporation from June 2014 until its acquisition by St. Jude Medical, Inc. in October 2015. Prior to joining Thoratec, Dr. Padmanabhan served in several roles of increasing responsibility for 18 years with Medtronic plc in their Cardiac Rhythm Management business, including as Vice President of Product Development for the Implantable Defibrillator Business and as Vice President of Connected Care R&D and Operations.
- Thomas Erickson
-
Thomas Erickson，2012年11月至2015年9月担任牙科服务提供商Western Dental Services, Inc主席；2013年4月至2014年1月，担任Western Dental Services, Inc临时首席执行官，2010年4月至2014年2月，担任逆向物流和收入回收公司Inmar, Inc董事会主席。Mr. Erickson还曾担任私募股权投资公司New Mountain Capital, LLC高级咨询顾问；公开上市的医药福利管理商National Medical Health Card Systems, Inc主席兼临时总裁；急性护理设施运营商PathWays, Inc董事会主席；保健服务公司TransHealthcare, Inc董事会主席；长期急性护理医院运营商 LifeCare Holdings, Inc.主席兼临时首席执行官；Luminex Corporation临时总裁兼首席执行官以及Interim President and Chief Executive Officer of 公开上市的医疗保健和房地产投资信托Omega Healthcare Investors, Inc临时总裁兼首席执行官。Mr. Erickson还曾是医师执业管理公司CareSelect Group, Inc的联合创始人，总裁兼首席执行官。Mr. Erickson现任American Renal Associates, Luminex Corporation和Syncreon Group Holdings Limited董事。
Thomas Erickson has most recently served as Chairman of Western Dental Services, Inc., a dental services provider, from November 2012 to September 2015; Interim Chief Executive Officer of Western Dental Services, Inc. from April 2013 to January 2014 and Chairman of the Board of Inmar, Inc., a reverse logistics and revenue recovery company, from April 2010 to February 2014. Mr. Erickson has also served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm; Chairman and Interim President of National Medical Health Card Systems, Inc., a publicly traded pharmacy benefits manager; Chairman of the Board of PathWays, Inc., an operator of post-acute care facilities; Chairman of the Board of TransHealthcare, Inc., a health care services company; Chairman and Interim Chief Executive Officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals; Interim President and Chief Executive Officer of Luminex Corporation, a publicly traded biotechnology company; and Interim President and Chief Executive Officer of Omega Healthcare Investors, Inc., a publicly traded healthcare focused real estate investment trust. Mr. Erickson was also co-founder, President and Chief Executive Officer of CareSelect Group, Inc., a physician practice management company. Mr. Erickson is currently a Director of American Renal Associates, Luminex Corporation, and Syncreon Group Holdings Limited. - Thomas Erickson，2012年11月至2015年9月担任牙科服务提供商Western Dental Services, Inc主席；2013年4月至2014年1月，担任Western Dental Services, Inc临时首席执行官，2010年4月至2014年2月，担任逆向物流和收入回收公司Inmar, Inc董事会主席。Mr. Erickson还曾担任私募股权投资公司New Mountain Capital, LLC高级咨询顾问；公开上市的医药福利管理商National Medical Health Card Systems, Inc主席兼临时总裁；急性护理设施运营商PathWays, Inc董事会主席；保健服务公司TransHealthcare, Inc董事会主席；长期急性护理医院运营商 LifeCare Holdings, Inc.主席兼临时首席执行官；Luminex Corporation临时总裁兼首席执行官以及Interim President and Chief Executive Officer of 公开上市的医疗保健和房地产投资信托Omega Healthcare Investors, Inc临时总裁兼首席执行官。Mr. Erickson还曾是医师执业管理公司CareSelect Group, Inc的联合创始人，总裁兼首席执行官。Mr. Erickson现任American Renal Associates, Luminex Corporation和Syncreon Group Holdings Limited董事。
- Thomas Erickson has most recently served as Chairman of Western Dental Services, Inc., a dental services provider, from November 2012 to September 2015; Interim Chief Executive Officer of Western Dental Services, Inc. from April 2013 to January 2014 and Chairman of the Board of Inmar, Inc., a reverse logistics and revenue recovery company, from April 2010 to February 2014. Mr. Erickson has also served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm; Chairman and Interim President of National Medical Health Card Systems, Inc., a publicly traded pharmacy benefits manager; Chairman of the Board of PathWays, Inc., an operator of post-acute care facilities; Chairman of the Board of TransHealthcare, Inc., a health care services company; Chairman and Interim Chief Executive Officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals; Interim President and Chief Executive Officer of Luminex Corporation, a publicly traded biotechnology company; and Interim President and Chief Executive Officer of Omega Healthcare Investors, Inc., a publicly traded healthcare focused real estate investment trust. Mr. Erickson was also co-founder, President and Chief Executive Officer of CareSelect Group, Inc., a physician practice management company. Mr. Erickson is currently a Director of American Renal Associates, Luminex Corporation, and Syncreon Group Holdings Limited.
- John J. Tracy
-
John J. Tracy，2016年从The Boeing Company退休，担任首席技术官兼工程、运营和技术高级副总裁，拥有超过37年的航空航天行业经验。在此之前，他曾在The Boeing Company担任波音综合防御系统工程和任务保障副总裁，以及Phantom Works结构技术、原型设计和质量副总裁，此前他曾在Hercules、McDonnell Douglas和The Boeing Company担任越来越重要的职务。Tracy博士是美国国家工程院院士。
John J. Tracy,retired from The Boeing Company in 2016 as its Chief Technology Officer and Senior Vice President, Engineering, Operations, and Technology with more than 37 years of aerospace-industry experience. Prior to that he served as Vice President, Engineering and Mission Assurance for Boeing Integrated Defense Systems and Vice President Structural Technologies, Prototyping and Quality of Phantom Works at The Boeing Company, after serving in roles of increasing responsibility at Hercules, McDonnell Douglas and The Boeing Company. Dr. Tracy is a member of the National Academy of Engineering. - John J. Tracy，2016年从The Boeing Company退休，担任首席技术官兼工程、运营和技术高级副总裁，拥有超过37年的航空航天行业经验。在此之前，他曾在The Boeing Company担任波音综合防御系统工程和任务保障副总裁，以及Phantom Works结构技术、原型设计和质量副总裁，此前他曾在Hercules、McDonnell Douglas和The Boeing Company担任越来越重要的职务。Tracy博士是美国国家工程院院士。
- John J. Tracy,retired from The Boeing Company in 2016 as its Chief Technology Officer and Senior Vice President, Engineering, Operations, and Technology with more than 37 years of aerospace-industry experience. Prior to that he served as Vice President, Engineering and Mission Assurance for Boeing Integrated Defense Systems and Vice President Structural Technologies, Prototyping and Quality of Phantom Works at The Boeing Company, after serving in roles of increasing responsibility at Hercules, McDonnell Douglas and The Boeing Company. Dr. Tracy is a member of the National Academy of Engineering.
- Malissia R. Clinton
-
Malissia R. Clinton自2022年4月起担任美国第五大公共住宅建筑商Meritage Homes Corporation的执行副总裁兼总法律顾问，此前曾于2009年至2022年3月期间担任航空航天公司的高级副总裁、总法律顾问和秘书，该公司是一家为太空任务的各个方面提供技术指导和建议的非营利性公司。她于2002年至2009年在诺斯罗普·格鲁门工作，包括从2007年开始担任特别项目的高级法律顾问。在加入诺斯罗普·格鲁门之前，Clinton女士曾任职于TRW，Inc.的一个部门TRW Space Technology，担任其电信程序和航空电子系统部门的法律顾问。她的职业生涯始于Tuttle & Taylor的合伙人。
Malissia R. Clinton,has served as Executive Vice President and General Counsel of Meritage Homes Corporation, the fifth-largest public homebuilder in the United States, since April 2022 and previously served as Senior Vice President, General Counsel and Secretary at The Aerospace Corporation, a nonprofit corporation that provides technical guidance and advice on all aspects of space missions, from 2009 through March 2022. She worked at Northrop Grumman from 2002 to 2009, including as Senior Counsel for Special Projects beginning in 2007. Prior to joining Northrop Grumman, Ms. Clinton worked at TRW Space Technology, a division of TRW, Inc., as Counsel in its Telecommunication Programs and Avionic Systems division. She began her career as an Associate at Tuttle & Taylor. - Malissia R. Clinton自2022年4月起担任美国第五大公共住宅建筑商Meritage Homes Corporation的执行副总裁兼总法律顾问，此前曾于2009年至2022年3月期间担任航空航天公司的高级副总裁、总法律顾问和秘书，该公司是一家为太空任务的各个方面提供技术指导和建议的非营利性公司。她于2002年至2009年在诺斯罗普·格鲁门工作，包括从2007年开始担任特别项目的高级法律顾问。在加入诺斯罗普·格鲁门之前，Clinton女士曾任职于TRW，Inc.的一个部门TRW Space Technology，担任其电信程序和航空电子系统部门的法律顾问。她的职业生涯始于Tuttle & Taylor的合伙人。
- Malissia R. Clinton,has served as Executive Vice President and General Counsel of Meritage Homes Corporation, the fifth-largest public homebuilder in the United States, since April 2022 and previously served as Senior Vice President, General Counsel and Secretary at The Aerospace Corporation, a nonprofit corporation that provides technical guidance and advice on all aspects of space missions, from 2009 through March 2022. She worked at Northrop Grumman from 2002 to 2009, including as Senior Counsel for Special Projects beginning in 2007. Prior to joining Northrop Grumman, Ms. Clinton worked at TRW Space Technology, a division of TRW, Inc., as Counsel in its Telecommunication Programs and Avionic Systems division. She began her career as an Associate at Tuttle & Taylor.
- Claudia N. Drayton
-
Claudia N. Drayton，于2021年4月至2023年6月期间，担任生命科学工具公司Quantum-Si的首席财务官（“CFO”），该公司将独特的蛋白质测序平台商业化。此前，她于2015年1月至2021年4月在早期医疗器械公司CHF Solutions（现Nuwellis, Inc.）担任首席财务官。在加入CHF Solutions之前，Drayton女士在美敦力公司工作了15年。在加入美敦力之前，Drayton女士是Arthur Andersen LLP的审计和业务咨询经理。
Claudia N. Drayton,served as the Chief Financial Officer of Quantum-Si, a life sciences tools company commercializing a unique protein sequencing platform, from April 2021 to June 2023. Previously, she served as Chief Financial Officer at CHF Solutions, an early-stage medical device company, from January 2015 to April 2021, a global leader in medical devices, where she held multiple senior roles concluding with Chief Financial Officer. Prior to joining CHF Solutions, Ms. Drayton spent 15 years with Medtronic plc. Ms. Drayton also was Chief Financial Officer of Medtronic's Peripheral Vascular Business while she was on an expatriate assignment in Europe. Before joining Medtronic, Ms. Drayton was an audit and business advisory manager at Arthur Andersen LLP. Ms. Drayton is National Association of Corporate Directors (NACD) Directorship Certified. - Claudia N. Drayton，于2021年4月至2023年6月期间，担任生命科学工具公司Quantum-Si的首席财务官（“CFO”），该公司将独特的蛋白质测序平台商业化。此前，她于2015年1月至2021年4月在早期医疗器械公司CHF Solutions（现Nuwellis, Inc.）担任首席财务官。在加入CHF Solutions之前，Drayton女士在美敦力公司工作了15年。在加入美敦力之前，Drayton女士是Arthur Andersen LLP的审计和业务咨询经理。
- Claudia N. Drayton,served as the Chief Financial Officer of Quantum-Si, a life sciences tools company commercializing a unique protein sequencing platform, from April 2021 to June 2023. Previously, she served as Chief Financial Officer at CHF Solutions, an early-stage medical device company, from January 2015 to April 2021, a global leader in medical devices, where she held multiple senior roles concluding with Chief Financial Officer. Prior to joining CHF Solutions, Ms. Drayton spent 15 years with Medtronic plc. Ms. Drayton also was Chief Financial Officer of Medtronic's Peripheral Vascular Business while she was on an expatriate assignment in Europe. Before joining Medtronic, Ms. Drayton was an audit and business advisory manager at Arthur Andersen LLP. Ms. Drayton is National Association of Corporate Directors (NACD) Directorship Certified.
- Jim D. Kever
-
Jim D. Kever， 他是投资合伙公司Voyent Partners, LLC的创始合伙人， 该公司成立于2001年。他还是3D Systems Corporation和Luminex Corporation的董事，曾担任ACI Worldwide, Inc.和Emdeon Corporation的董事。1999年起，他担任董事会成员。他有丰富的资本市场和公司财务经验，有资格在证券交易委员会规定下担任审计委员会财政专家。他在多个行业多家公司担任董事经验为他提供了对公司面临挑战和事务独到的见解和理解处理的能力。
Jim D. Kever,has been a Principal of Voyent Partners, LLC, a venture capital firm, since 2001. He previously served as President and Co-Chief Executive Officer of the Transaction Services Division of WebMD Corporation (formerly Envoy Corporation) from 1995 to 2001. Prior to 1995 he served as Envoy Corporation's Executive Vice President, Secretary and General Counsel. - Jim D. Kever， 他是投资合伙公司Voyent Partners, LLC的创始合伙人， 该公司成立于2001年。他还是3D Systems Corporation和Luminex Corporation的董事，曾担任ACI Worldwide, Inc.和Emdeon Corporation的董事。1999年起，他担任董事会成员。他有丰富的资本市场和公司财务经验，有资格在证券交易委员会规定下担任审计委员会财政专家。他在多个行业多家公司担任董事经验为他提供了对公司面临挑战和事务独到的见解和理解处理的能力。
- Jim D. Kever,has been a Principal of Voyent Partners, LLC, a venture capital firm, since 2001. He previously served as President and Co-Chief Executive Officer of the Transaction Services Division of WebMD Corporation (formerly Envoy Corporation) from 1995 to 2001. Prior to 1995 he served as Envoy Corporation's Executive Vice President, Secretary and General Counsel.
- Kevin S. Moore
-
Kevin S. Moore，10余年来，他一直在克拉克置业公司，这是一家私人投资公司，在那里他现任总裁兼董事。他也是Aspect控股有限责任公司、克拉克基金会和 National Baseball Hall of Fame & Museum有限公司的董事；巴塞特医疗保健网络的董事会副主席。
Kevin S. Moore,has been with The Clark Estates, Inc., a private investment firm and a major company stockholder, for more than 30 years, where he is Vice Chairman and Director. - Kevin S. Moore，10余年来，他一直在克拉克置业公司，这是一家私人投资公司，在那里他现任总裁兼董事。他也是Aspect控股有限责任公司、克拉克基金会和 National Baseball Hall of Fame & Museum有限公司的董事；巴塞特医疗保健网络的董事会副主席。
- Kevin S. Moore,has been with The Clark Estates, Inc., a private investment firm and a major company stockholder, for more than 30 years, where he is Vice Chairman and Director.
- Charles G. McClure, Jr.
-
Charles G. McClure, Jr.，自2014年起担任私人投资公司Michigen Capital Advisors的管理合伙人，在交通运输行业拥有超过35年的经验。在创立Michigan Capital Advisors之前，McClure先生曾于2004年至2013年担任Meritor，Inc.的董事会主席、首席执行官和总裁。从2002年到2004年，McClure先生曾担任Federal Mogul Corp.的首席执行官、总裁和董事会成员。McClure先生于2001年加入Federal Mogul，担任总裁、首席运营官和董事会成员。在加入Federal Mogul之前，McClure先生曾担任Detroit Diesel的总裁、首席执行官和董事会成员。在江森自控担任多个管理职位14年后，他于1997年加入底特律柴油公司。
Charles G. McClure, Jr.,has served as a Managing Partner of Michigan Capital Advisors, a private investment firm, since 2014 and has more than 35 years of experience in the transportation industry. Prior to founding Michigan Capital Advisors, Mr. McClure served as Chair of the Board, Chief Executive Officer and President of Meritor, Inc. from 2004 through 2013. From 2002 through 2004, Mr. McClure served as Chief Executive Officer, President and a member of the Board of Federal Mogul Corp. Mr. McClure joined Federal Mogul in 2001 as President, Chief Operating Officer and a member of the Board. Before joining Federal Mogul, Mr. McClure served as President, Chief Executive Officer and a member of the Board of Detroit Diesel. He joined Detroit Diesel in 1997 after 14 years in a variety of management positions with Johnson Controls. - Charles G. McClure, Jr.，自2014年起担任私人投资公司Michigen Capital Advisors的管理合伙人，在交通运输行业拥有超过35年的经验。在创立Michigan Capital Advisors之前，McClure先生曾于2004年至2013年担任Meritor，Inc.的董事会主席、首席执行官和总裁。从2002年到2004年，McClure先生曾担任Federal Mogul Corp.的首席执行官、总裁和董事会成员。McClure先生于2001年加入Federal Mogul，担任总裁、首席运营官和董事会成员。在加入Federal Mogul之前，McClure先生曾担任Detroit Diesel的总裁、首席执行官和董事会成员。在江森自控担任多个管理职位14年后，他于1997年加入底特律柴油公司。
- Charles G. McClure, Jr.,has served as a Managing Partner of Michigan Capital Advisors, a private investment firm, since 2014 and has more than 35 years of experience in the transportation industry. Prior to founding Michigan Capital Advisors, Mr. McClure served as Chair of the Board, Chief Executive Officer and President of Meritor, Inc. from 2004 through 2013. From 2002 through 2004, Mr. McClure served as Chief Executive Officer, President and a member of the Board of Federal Mogul Corp. Mr. McClure joined Federal Mogul in 2001 as President, Chief Operating Officer and a member of the Board. Before joining Federal Mogul, Mr. McClure served as President, Chief Executive Officer and a member of the Board of Detroit Diesel. He joined Detroit Diesel in 1997 after 14 years in a variety of management positions with Johnson Controls.
- Jeffrey A. Graves
-
Jeffrey A. Graves， 自2007年任Teleflex公司董事，现为薪酬委员会委员。自2012年5月任MTS系统公司总裁及首席执行官。该公司主要提供机械测试系统及机械自动化位置传感器。自2005年7月至2012年5月，他曾为C&D技术公司总裁及首席执行官，该公司主要提供电力储藏系统。自2001年至2005年，他曾受雇于Kemet公司，自2003年至2005年在此公司担任首席执行官一职，自2002年至2003年任公司总裁及首席营运官，自2001年至2002年任公司技术工程部副总裁，自1994年至2001年Graves博士受雇于General Electric Company，并在公司电力资源部及科研发展部任职，在加入通用电气公司之前，Graves博士曾受雇于Rockwell国际公司及Howmet公司，现为Alcoa旗下公司。Graves博士现为MTS系统公司及Hexcel公司董事。
Jeffrey A. Graves,was appointed the Company's President and Chief Executive Officer in May 2020. Prior to joining the Company, from 2012 to May 2020, Dr. Graves served as Chief Executive Officer, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement systems. From 2005 until 2012, Dr. Graves served as President and Chief Executive Officer of C&D Technologies, Inc., a technology company that produces and markets systems for the power conversion and storage of electrical power. Dr. Graves also held leadership roles with Kemet Corporation, an electronic component manufacturing company, as Chief Operating Officer from 2001 to 2003 and Chief Executive Officer from 2003 to 2005. Previously, he held a number of leadership and technical roles with General Electric, Rockwell Automation and Howmet Corporation. In addition to serving on the Company's Board of Directors, Dr. Graves has served on the board of directors of Integra Lifesciences Holdings Corporation since December 2023. He retired from his position on the board of directors of Hexcel Corporation in May 2024, having served as a Director of Hexcel since 2007. In addition to Integra and Hexcel, Dr. Graves previously served as a director of FARO Technologies and Teleflex Corporation. - Jeffrey A. Graves， 自2007年任Teleflex公司董事，现为薪酬委员会委员。自2012年5月任MTS系统公司总裁及首席执行官。该公司主要提供机械测试系统及机械自动化位置传感器。自2005年7月至2012年5月，他曾为C&D技术公司总裁及首席执行官，该公司主要提供电力储藏系统。自2001年至2005年，他曾受雇于Kemet公司，自2003年至2005年在此公司担任首席执行官一职，自2002年至2003年任公司总裁及首席营运官，自2001年至2002年任公司技术工程部副总裁，自1994年至2001年Graves博士受雇于General Electric Company，并在公司电力资源部及科研发展部任职，在加入通用电气公司之前，Graves博士曾受雇于Rockwell国际公司及Howmet公司，现为Alcoa旗下公司。Graves博士现为MTS系统公司及Hexcel公司董事。
- Jeffrey A. Graves,was appointed the Company's President and Chief Executive Officer in May 2020. Prior to joining the Company, from 2012 to May 2020, Dr. Graves served as Chief Executive Officer, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement systems. From 2005 until 2012, Dr. Graves served as President and Chief Executive Officer of C&D Technologies, Inc., a technology company that produces and markets systems for the power conversion and storage of electrical power. Dr. Graves also held leadership roles with Kemet Corporation, an electronic component manufacturing company, as Chief Operating Officer from 2001 to 2003 and Chief Executive Officer from 2003 to 2005. Previously, he held a number of leadership and technical roles with General Electric, Rockwell Automation and Howmet Corporation. In addition to serving on the Company's Board of Directors, Dr. Graves has served on the board of directors of Integra Lifesciences Holdings Corporation since December 2023. He retired from his position on the board of directors of Hexcel Corporation in May 2024, having served as a Director of Hexcel since 2007. In addition to Integra and Hexcel, Dr. Graves previously served as a director of FARO Technologies and Teleflex Corporation.
高管简历
中英对照 | 中文 | 英文- Reji Puthenveetil
Reji Puthenveetil，工业解决方案执行副总裁。Puthenveetil先生自2020年7月起担任工业解决方案执行副总裁。在加入公司之前，Puthenveetil先生担任了25年的管理顾问，帮助多个行业的公司设计明确的增长战略，并确保组织能力和执行的一致性。
Reji Puthenveetil,was promoted to his current role in January 2024 and has responsibility for the Company's commercial operations for both the Healthcare Solutions and Industrial Solutions business units. In July 2020, Mr. Puthenveetil joined the Company as Executive Vice President, Industrial Solutions. Prior to joining the Company, Mr. Puthenveetil spent 25 years as a management consultant for Group Newhouse helping companies, such as Lockheed Martin, Xcel Energy, Kia Motors, and Thales Group.- Reji Puthenveetil，工业解决方案执行副总裁。Puthenveetil先生自2020年7月起担任工业解决方案执行副总裁。在加入公司之前，Puthenveetil先生担任了25年的管理顾问，帮助多个行业的公司设计明确的增长战略，并确保组织能力和执行的一致性。
- Reji Puthenveetil,was promoted to his current role in January 2024 and has responsibility for the Company's commercial operations for both the Healthcare Solutions and Industrial Solutions business units. In July 2020, Mr. Puthenveetil joined the Company as Executive Vice President, Industrial Solutions. Prior to joining the Company, Mr. Puthenveetil spent 25 years as a management consultant for Group Newhouse helping companies, such as Lockheed Martin, Xcel Energy, Kia Motors, and Thales Group.
- Phyllis Nordstrom
Phyllis Nordstrom，自2021年8月起担任执行副总裁、首席人员和文化官以及首席合规官。自2022年12月起，她被进一步任命为公司首席行政官。在加入3D系统之前，2016年5月至2021年7月，Nordstrom女士在MTS系统科技公司担任高级副总裁兼首席风险与合规官，担任商业道德、公司合规、公司可持续发展以及内部审计和风险管理方面的负责人。在22年的职业生涯中，诺德斯特罗姆还在普华永道、塔吉特和美国银行担任过多个领导职务。
Phyllis Nordstrom,has served as Executive Vice President, Chief People Officer and Chief Compliance Officer since August 2021. Effective December 2022, she was further appointed as the Company's Chief Administrative Officer. Prior to joining 3D Systems, from May 2016 through July 2021, Ms. Nordstrom was Senior Vice President and Chief Risk & Compliance Officer at MTS Systems Corporation, where she was the leader of business ethics, corporate compliance, corporate sustainability, and internal audit and risk management. Over her 25-year career, Ms. Nordstrom has also held leadership roles at PricewaterhouseCoopers, Target, and US Bank.- Phyllis Nordstrom，自2021年8月起担任执行副总裁、首席人员和文化官以及首席合规官。自2022年12月起，她被进一步任命为公司首席行政官。在加入3D系统之前，2016年5月至2021年7月，Nordstrom女士在MTS系统科技公司担任高级副总裁兼首席风险与合规官，担任商业道德、公司合规、公司可持续发展以及内部审计和风险管理方面的负责人。在22年的职业生涯中，诺德斯特罗姆还在普华永道、塔吉特和美国银行担任过多个领导职务。
- Phyllis Nordstrom,has served as Executive Vice President, Chief People Officer and Chief Compliance Officer since August 2021. Effective December 2022, she was further appointed as the Company's Chief Administrative Officer. Prior to joining 3D Systems, from May 2016 through July 2021, Ms. Nordstrom was Senior Vice President and Chief Risk & Compliance Officer at MTS Systems Corporation, where she was the leader of business ethics, corporate compliance, corporate sustainability, and internal audit and risk management. Over her 25-year career, Ms. Nordstrom has also held leadership roles at PricewaterhouseCoopers, Target, and US Bank.
- Joseph Zuiker
Joseph Zuiker，自2022年12月起担任工程和运营执行副总裁。在加入3D系统之前，Zuiker博士曾于2017年7月至2022年12月在MTS系统科技公司担任工程、运营和订单履行副总裁。在加入MTS系统科技之前，他于2011年9月至2016年7月担任哈里伯顿 Corporation的Sperry Drilling的技术高级总监。Zuiker博士还曾于1995年12月至2011年8月任职于通用电气，担任过各种职务，职责不断增加，包括GE气化技术总经理、GE Hydro技术总经理、六西格玛大师黑带。
Joseph Zuiker,has served as Executive Vice President of Engineering and Operations since December 2022. Prior to joining 3D Systems, Dr. Zuiker served as Vice President of Engineering, Operations, and Order Fulfillment for MTS Systems Corporation where he worked from July 2017 until December 2022. Prior to joining MTS Systems, he was Senior Director of Technology for Halliburton Corporation's Sperry Drilling from September 2011 to July 2016. Dr. Zuiker also worked for General Electric from December 1995 to August 2011 in various roles of increasing responsibility, including General Manager of GE Gasification Technology and General Manager of GE Hydro Technology. Dr. Zuiker is also a Six Sigma Master Black Belt.- Joseph Zuiker，自2022年12月起担任工程和运营执行副总裁。在加入3D系统之前，Zuiker博士曾于2017年7月至2022年12月在MTS系统科技公司担任工程、运营和订单履行副总裁。在加入MTS系统科技之前，他于2011年9月至2016年7月担任哈里伯顿 Corporation的Sperry Drilling的技术高级总监。Zuiker博士还曾于1995年12月至2011年8月任职于通用电气，担任过各种职务，职责不断增加，包括GE气化技术总经理、GE Hydro技术总经理、六西格玛大师黑带。
- Joseph Zuiker,has served as Executive Vice President of Engineering and Operations since December 2022. Prior to joining 3D Systems, Dr. Zuiker served as Vice President of Engineering, Operations, and Order Fulfillment for MTS Systems Corporation where he worked from July 2017 until December 2022. Prior to joining MTS Systems, he was Senior Director of Technology for Halliburton Corporation's Sperry Drilling from September 2011 to July 2016. Dr. Zuiker also worked for General Electric from December 1995 to August 2011 in various roles of increasing responsibility, including General Manager of GE Gasification Technology and General Manager of GE Hydro Technology. Dr. Zuiker is also a Six Sigma Master Black Belt.
- Andrew W. B. Wright
Andrew W. B. Wright，自2024年6月起担任高级副总裁、总法律顾问和秘书。加入3D系统之前，2017年11月至2024年6月，他担任Akoustis技术公司总法律顾问和秘书。在加入Akoustis之前，2013年8月至2017年11月，他在Toshiba Global Commerce Solutions，Inc.担任助理总法律顾问和副总法律顾问职务。在加入Toshiba Global Commerce Solutions之前，1998年1月至2013年8月，他在为IBM系统和技术集团以及IBM软件集团提供支持的IBM Corporation法律部门内担任越来越多的职责。在加入IBM公司之前，1994年8月至1997年12月，Wright先生曾在Parker，POE，Adams & Bernstein L.L.P.工作。
Andrew W. B. Wright,has served as Senior Vice President, General Counsel and Secretary since June 2024. Prior to joining 3D Systems, from November 2017 to June 2024, he was General Counsel and Secretary for Akoustis Technologies, Inc. Prior to joining Akoustis, from August 2013 to November 2017, he held Assistant General Counsel and Associate General Counsel roles at Toshiba Global Commerce Solutions, Inc. Prior to joining Toshiba Global Commerce Solutions, from January 1998 to August 2013, he held multiple roles of increasing responsibility within the IBM Corporation legal department supporting IBM Systems and Technology Group and IBM Software Group. Prior to joining IBM Corporation, from August 1994 to December 1997, Mr. Wright worked at Parker, Poe, Adams & Bernstein L.L.P.- Andrew W. B. Wright，自2024年6月起担任高级副总裁、总法律顾问和秘书。加入3D系统之前，2017年11月至2024年6月，他担任Akoustis技术公司总法律顾问和秘书。在加入Akoustis之前，2013年8月至2017年11月，他在Toshiba Global Commerce Solutions，Inc.担任助理总法律顾问和副总法律顾问职务。在加入Toshiba Global Commerce Solutions之前，1998年1月至2013年8月，他在为IBM系统和技术集团以及IBM软件集团提供支持的IBM Corporation法律部门内担任越来越多的职责。在加入IBM公司之前，1994年8月至1997年12月，Wright先生曾在Parker，POE，Adams & Bernstein L.L.P.工作。
- Andrew W. B. Wright,has served as Senior Vice President, General Counsel and Secretary since June 2024. Prior to joining 3D Systems, from November 2017 to June 2024, he was General Counsel and Secretary for Akoustis Technologies, Inc. Prior to joining Akoustis, from August 2013 to November 2017, he held Assistant General Counsel and Associate General Counsel roles at Toshiba Global Commerce Solutions, Inc. Prior to joining Toshiba Global Commerce Solutions, from January 1998 to August 2013, he held multiple roles of increasing responsibility within the IBM Corporation legal department supporting IBM Systems and Technology Group and IBM Software Group. Prior to joining IBM Corporation, from August 1994 to December 1997, Mr. Wright worked at Parker, Poe, Adams & Bernstein L.L.P.
- Charles W. Hull
Charles W. Hull，他担任公司的执行副总裁兼首席技术官。5年多来，他曾担任董事和3D Systems Corporation的各种行政职务。他是公司创办人，自1997年以来担任首席技术官，自2000年以来一直担任执行副总裁。他还曾经担任其他各种3D Systems Corporation的执行职务，包括行政总裁、董事局副主席，并担任总裁兼首席营运官。
Charles W. Hull,is a founder of the Company and served as a member of 3d Systems Corporation Board of Directors from 1993 to May 2022 when he was designated Director Emeritus. He has served as Chief Technology Officer since 1997, as Executive Vice President since 2000 and as Chief Technology Officer for Regenerative Medicine since 2021. Mr. Hull has also previously served in various other executive capacities at the Company since 1986, including Chief Executive Officer, Vice Chairman of the Board of Directors and President and Chief Operating Officer.- Charles W. Hull，他担任公司的执行副总裁兼首席技术官。5年多来，他曾担任董事和3D Systems Corporation的各种行政职务。他是公司创办人，自1997年以来担任首席技术官，自2000年以来一直担任执行副总裁。他还曾经担任其他各种3D Systems Corporation的执行职务，包括行政总裁、董事局副主席，并担任总裁兼首席营运官。
- Charles W. Hull,is a founder of the Company and served as a member of 3d Systems Corporation Board of Directors from 1993 to May 2022 when he was designated Director Emeritus. He has served as Chief Technology Officer since 1997, as Executive Vice President since 2000 and as Chief Technology Officer for Regenerative Medicine since 2021. Mr. Hull has also previously served in various other executive capacities at the Company since 1986, including Chief Executive Officer, Vice Chairman of the Board of Directors and President and Chief Operating Officer.
- Jeffrey A. Graves
Jeffrey A. Graves， 自2007年任Teleflex公司董事，现为薪酬委员会委员。自2012年5月任MTS系统公司总裁及首席执行官。该公司主要提供机械测试系统及机械自动化位置传感器。自2005年7月至2012年5月，他曾为C&D技术公司总裁及首席执行官，该公司主要提供电力储藏系统。自2001年至2005年，他曾受雇于Kemet公司，自2003年至2005年在此公司担任首席执行官一职，自2002年至2003年任公司总裁及首席营运官，自2001年至2002年任公司技术工程部副总裁，自1994年至2001年Graves博士受雇于General Electric Company，并在公司电力资源部及科研发展部任职，在加入通用电气公司之前，Graves博士曾受雇于Rockwell国际公司及Howmet公司，现为Alcoa旗下公司。Graves博士现为MTS系统公司及Hexcel公司董事。
Jeffrey A. Graves,was appointed the Company's President and Chief Executive Officer in May 2020. Prior to joining the Company, from 2012 to May 2020, Dr. Graves served as Chief Executive Officer, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement systems. From 2005 until 2012, Dr. Graves served as President and Chief Executive Officer of C&D Technologies, Inc., a technology company that produces and markets systems for the power conversion and storage of electrical power. Dr. Graves also held leadership roles with Kemet Corporation, an electronic component manufacturing company, as Chief Operating Officer from 2001 to 2003 and Chief Executive Officer from 2003 to 2005. Previously, he held a number of leadership and technical roles with General Electric, Rockwell Automation and Howmet Corporation. In addition to serving on the Company's Board of Directors, Dr. Graves has served on the board of directors of Integra Lifesciences Holdings Corporation since December 2023. He retired from his position on the board of directors of Hexcel Corporation in May 2024, having served as a Director of Hexcel since 2007. In addition to Integra and Hexcel, Dr. Graves previously served as a director of FARO Technologies and Teleflex Corporation.- Jeffrey A. Graves， 自2007年任Teleflex公司董事，现为薪酬委员会委员。自2012年5月任MTS系统公司总裁及首席执行官。该公司主要提供机械测试系统及机械自动化位置传感器。自2005年7月至2012年5月，他曾为C&D技术公司总裁及首席执行官，该公司主要提供电力储藏系统。自2001年至2005年，他曾受雇于Kemet公司，自2003年至2005年在此公司担任首席执行官一职，自2002年至2003年任公司总裁及首席营运官，自2001年至2002年任公司技术工程部副总裁，自1994年至2001年Graves博士受雇于General Electric Company，并在公司电力资源部及科研发展部任职，在加入通用电气公司之前，Graves博士曾受雇于Rockwell国际公司及Howmet公司，现为Alcoa旗下公司。Graves博士现为MTS系统公司及Hexcel公司董事。
- Jeffrey A. Graves,was appointed the Company's President and Chief Executive Officer in May 2020. Prior to joining the Company, from 2012 to May 2020, Dr. Graves served as Chief Executive Officer, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement systems. From 2005 until 2012, Dr. Graves served as President and Chief Executive Officer of C&D Technologies, Inc., a technology company that produces and markets systems for the power conversion and storage of electrical power. Dr. Graves also held leadership roles with Kemet Corporation, an electronic component manufacturing company, as Chief Operating Officer from 2001 to 2003 and Chief Executive Officer from 2003 to 2005. Previously, he held a number of leadership and technical roles with General Electric, Rockwell Automation and Howmet Corporation. In addition to serving on the Company's Board of Directors, Dr. Graves has served on the board of directors of Integra Lifesciences Holdings Corporation since December 2023. He retired from his position on the board of directors of Hexcel Corporation in May 2024, having served as a Director of Hexcel since 2007. In addition to Integra and Hexcel, Dr. Graves previously served as a director of FARO Technologies and Teleflex Corporation.